How Similar Are States' Medicaid Preferred Drug Lists?
Comparison of the generosity and consistency of 10 states' Medicaid preferred drug lists for the top therapeutic classes revealed a large degree of inconsistency.
Systematic Analysis of Outcomes Evaluations Applied to Drug Management Programs
Adopting quality measurement standards for drug management programs might increase the effectiveness and long-term sustainability of positive health outcomes for patients.
Medicare Part D Formulary Coverage Since Program Inception: Are Beneficiaries Choosing Wisely?
Analysis of Medicare Part D formulary composition since program inception suggests beneficiaries may not be using their open-enrollment periods to reevaluate available plan offerings.
Impact of Therapeutic Switching in Long-Term Care
Switching medications for nonmedical (formulary) reasons in long-term care settings may increase Medicare Part D resident adverse effects and raise facility downstream costs.
Medicare Part D's Effects on Elderly Patients' Drug Costs and Utilization
As a result of Medicare Part D, elderly patients' out-of-pocket costs for prescription drugs decreased and their utilization increased, mostly from 2005-2006.
Primary Care Physicians' Views of Medicare Part D
Primary care physicians have mixed views of prescription drug coverage under Medicare Part D.
2 Clarke Drive Cranbury, NJ 08512